The Pharmaceutical Quality Management Systems Market is expected to record a CAGR of 15.6% from 2023 to 2030, reaching $3.97 billion by 2030. A pharmaceutical quality management system is a collection of procedures, processes, and policies designed to ensure high product quality in pharmaceutical manufacturing. Pharmaceutical quality management systems reflect the specific needs of the pharmaceutical company and respective regulatory requirements. The reflected regulatory requirements for product quality help pharmaceutical companies mitigate risks, improve customer satisfaction, and streamline the quality process. The pharmaceutical quality management system encompasses several processes, including document management, change control, training management, audit management, and deviation management.
The growth of this market is driven by the increasing costs of drug manufacturing, pharmaceutical companies growing need to comply with regulatory requirements, the rapid growth of the pharmaceutical industry, and the benefits of software-based quality management systems. However, the high costs of deploying pharmaceutical quality management systems restrain the growth of this market.
The growing generic drugs & biopharmaceuticals markets and pharmaceutical companies' increasing preference for platform-as-a-service solutions are expected to generate growth opportunities for the players in this market. However, security concerns related to on-cloud deployments among pharmaceutical organizations are a major challenge for market growth.
Pharmaceutical products directly impact consumer health and well-being. Hence, these products are subject to stringent regulations. Pharmaceutical manufacturers must comply with safety and quality standards to bring their products to the market. With the rapid expansion of the pharma sector, small and mid-sized pharmaceutical players are focused on complying with regulations and investing in research and development to deliver better products to customers and stay competitive in the market. For instance, in 2021, Pharmaceutical Research and Manufacturers of America (PhRMA) member companies spent USD 102.3 billion on R&D, a significant increase over USD 91.1 billion in 2020 (Source: 2022 PhRMA member annual survey).
Most companies operating in developing countries such as India and China export their products to the U.S. These products are regulated by the U.S. Food and Drug Administration (FDA). To ensure the safety of pharmaceutical products sold in the U.S., the FDA inspects the facilities and procedures of all pharmaceutical manufacturers (in the U.S. and those overseas) that regularly sell their products in the U.S. Hence, these companies must be registered with the FDA and adhere to the FDA's current good manufacturing practices (cGMP). Additionally, manufacturers must follow ICH Guideline Q10, 21 CFR Part 211, and International Organization for Standardization (ISO) guidelines to produce and market their products. With the increasing importance of regulatory requirements and growing international markets, pharmaceutical manufacturers are keen on adopting quality management systems.
Growing Generic Drugs & Biopharmaceuticals Markets Generating Growth Opportunities for Market Players
The adoption of biopharmaceuticals is increasing faster compared to conventional synthetic drugs due to their ability to target specific molecules, lower side effects, and high activity and specificity. Biopharmaceuticals are increasingly being used for treating immune-mediated inflammatory diseases (IMIDs), including rheumatic diseases, such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and cancer. Quality management systems are essential in biopharmaceuticals to ensure standardized and high-quality products. Biopharmaceutical firms can ensure constant adherence to quality standards, compliance with regulations, and continual improvements in organizational processes by deploying QMS. Quality management systems allow pharmaceutical & biopharmaceutical companies to increase overall customer satisfaction, reduce the risk of product recalls, and improve product quality.
In 2023, the CAPA Management Segment is Expected to Grow at the Highest CAGR During the Forecast Period
The segment's growth can be attributed to several factors, including product quality, patient safety, and regulatory compliance. The primary concern of the pharmaceutical industry is the safety and well-being of patients who rely on their products. CAPA management helps identify and correct issues that could compromise patient safety, whether related to product quality, manufacturing processes, labeling, or packaging.
The Cloud/Web-based Segment is Expected to Account for the Largest Share of the Market
The large market share of this segment is attributed to the benefits offered by cloud/web-based deployments, such as cost-effectiveness, real-time analysis capabilities, easy access to data, internal and external data sharing, flexibility, and scalability.
Cloud/web-based models are rapidly gaining traction in the pharmaceutical quality management systems market. Using cloud-based systems does not involve hardware installation and maintenance costs and does not require maintaining in-house IT maintenance and support teams. Thus, the cost-effectiveness of cloud-based deployment makes it a viable option, even for small and medium-sized research laboratories.
Click here to: Get Free Sample Pages of this Report
The Pharmaceutical and Biotechnology Companies, Segment is Projected to Register the Fastest Growth During the Forecast Period
The factors propelling the segment's growth include frequent changes in the manufacturing process, stringent regulations, the mounting pressure to increase production capacity, governmental initiatives, and the rising costs associated with drug manufacturing.
The pharmaceutical and biopharmaceutical sectors have witnessed significant growth in recent years due to the increasing demand for pharmaceutical products, growing adoption of single-use products, growing incidences and prevalence of various chronic diseases, and mounting need to address unmet medical requirements for rare and chronic diseases. Additionally, governments of various countries are taking initiatives by making investments and providing grants and funds to pharmaceutical and biotechnology companies for the manufacture and R&D of biopharmaceuticals. For instance, in November 2021, Medical Research Agency (Poland) announced government funding of USD 73.3 million (PLN 300 million) for producing vaccines based on mRNA technology in Poland.
North America to Dominate the Market
In 2023, North America is expected to dominate the Pharmaceutical Quality Management Systems Market. The factors attributed to the large share are the increasing use of advanced digital tools approved by regulatory authorities in the pharmaceutical sector to improve overall process outcomes and the presence of major market players in the region. Along with this, the high spending power of small and midsized organizations strongly supports adopting quality management systems in the region.
Key Players
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in the last three to four years. The key players profiled in the Pharmaceutical Quality Management Systems Market are Honeywell International Inc. (U.S.), IQVIA Holdings Inc. (U.S.), ANTARES VISION S.p.A (Italy), Dassault Systèmes SE (France), EtQ Management Consultants, Inc. (U.S.), Ideagen PLC (U.K.), Körber AG (Germany), LogicGate, Inc. (U.S.), ComplianceQuest, Inc (U.S.), AssurX, Inc. (U.S.), and AXSource Consulting, Inc. (U.S.).
Scope of the Report:
Pharmaceutical Quality Management Systems Market Assessment, by Solution Type
Pharmaceutical Quality Management Systems Market Assessment, by Deployment Mode
Pharmaceutical Quality Management Systems Market Assessment, by End User
Pharmaceutical Quality Management Systems Market Assessment, by Geography
Key Questions Answered in the Report:
The Pharmaceutical Quality Management Systems Market report covers market sizes & forecasts for solution types. The Pharmaceutical Quality Management Systems Market study includes the value analysis of various segments and subsegments of the Pharmaceutical Quality Management Systems Market at the country & regional level.
The Pharmaceutical Quality Management Systems Market is projected to reach $3.97 billion by 2030, at a CAGR of 15.6% from 2023 to 2030.
The non-conformance/deviation management segment is estimated to account for the largest share of the Pharmaceutical Quality Management Systems Market in 2023.
The cloud/web-based segment is projected to gain more traction in the Pharmaceutical Quality Management Systems Market.
The growth of the Pharmaceutical Quality Management Systems Market is mainly attributed to the growth of this market is driven by the increasing costs of drug manufacturing, pharmaceutical companies’ growing need to comply with regulatory requirements, the rapid growth of the pharmaceutical industry, and the benefits of software-based quality management systems. Moreover, the growing generic drugs & biopharmaceuticals markets and pharmaceutical companies' increasing preference for platform-as-a-service solutions are expected to generate growth opportunities for the players in this market.
The key players operating in the Pharmaceutical Quality Management Systems Market are Honeywell International Inc. (U.S.), IQVIA Holdings Inc. (U.S.), ANTARES VISION S.p.A (Italy), Dassault Systèmes SE (France), EtQ Management Consultants, Inc. (U.S.), Ideagen PLC (U.K.), Körber AG (Germany), LogicGate, Inc. (U.S.), ComplianceQuest, Inc (U.S.), AssurX, Inc. (U.S.), and AXSource Consulting, Inc. (U.S.).
Emerging economies in Asia-Pacific, including China and India, are expected to offer growth opportunities for the players in this market. Government initiatives for improving domestic manufacturing, an established pharmaceutical market, increasing R&D expenditures by pharmaceutical and biopharmaceutical companies, favorable regulatory policies, and the surge in the aging population are the key factors driving the market's growth.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Pharmaceutical Companies’ Growing Need to Comply with Regulatory Requirements Driving the Adoption of Pharmaceutical Quality Management Systems
4.2.1.2. High Costs of Deploying Pharmaceutical Quality Management Systems Limiting their Adoption
4.2.1.3. Growing Generic Drugs & Biopharmaceuticals Markets Generating Growth Opportunities for Market Players
4.2.1.4. Security Concerns Related to On-cloud Deployments Impacting the Implementation of Pharmaceutical QMS
4.2.2. Factor Analysis
4.3. Trends
4.3.1. Integration Of Artificial Intelligence & Machine Learning into Pharmaceutical Quality Management Systems
4.3.2. Increasing Inclination Toward Personalized Medicine
4.4. Pharmaceutical Quality Management Systems Market: Regulatory Analysis
4.4.1. Overview
4.4.2. International Organization for Standardization (ISO)
4.4.3. Pharmaceutical Inspection Co-Operation Scheme (PIC/S)
4.4.4. ICH Guideline Q10
4.4.5. Current Good Manufacturing Practice (cGMP)
4.5. Pricing Analysis
4.6. Case Studies
5. Pharmaceutical Quality Management Systems Market Assessment—by Solution Type
5.1. Overview
5.2. Non-Conformance/Deviation Management
5.3. Document Management
5.4. CAPA Management
5.5. Risk & Compliance Management
5.6. Inspection Management
5.7. Audit Management
5.8. Suppliers & Materials Management
5.9. Training Management
5.10. Change Management
5.11. Other Solution Types
6. Pharmaceutical Quality Management Systems Market Assessment—by Deployment Mode
6.1. Overview
6.2. Cloud/Web-based
6.3. On Premise
7. Pharmaceutical Quality Management Systems Market Assessment—by End User
7.1. Overview
7.2. Pharmaceutical And Biotechnology Companies
7.3. Contract Development and Manufacturing Organization/ Contract Research Organization
7.4. Research Laboratories
8. Pharmaceutical Quality Management Systems Market Assessment—by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Ireland
8.3.7. Belgium
8.3.8. Netherlands
8.3.9. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Singapore
8.4.5. Malaysia
8.4.6. Philippines
8.4.7. Vietnam
8.4.8. Rest of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Players Ranking (2022)
10. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments, and SWOT Analysis)
10.1. Honeywell International Inc.
10.2. IQVIA Holdings Inc.
10.3. Dassault Systèmes SE
10.4. Körber AG
10.5. ANTARES VISION S.p.A.
10.6. EtQ Management Consultants Inc. (A Subsidiary of Hexagon AB)
10.7. Ideagen PLC (A Subsidiary of Rainforest Bidco Limited)
10.8. AssurX, Inc.
10.9. AXSource Consulting, Inc.
10.10. ComplianceQuest, Inc.
10.11. LogicGate, Inc.
10.12. MasterControl Solutions Inc.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Recent Biopharmaceutical Plant Capacity Expansions
Table 2 Overview of Product Lifecycle Stages
Table 3 Overview of Standards and Compliance Guidelines Related to Pharmaceutical Quality Management Systems
Table 4 GMP Regulations
Table 5 Pharmaceutical Quality Management Software: Pricing
Table 6 Global Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 7 Global Non-Conformance/Deviation Management Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Document Management Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global CAPA Management Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Risk & Compliance Management Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Inspection Management Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Audit Management Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Suppliers & Materials Management Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Training Management Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Change Management Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Other Solution Types Market, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 18 Global Cloud/Web-Based Pharmaceutical Quality Management Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Global On-Premise Pharmaceutical Quality Management Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 21 Global Pharma QMS Market for Pharmaceutical and Biotechnology Companies, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Pharma QMS Market For CDMO/CRO, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Pharma Quality Management Systems Market for Research Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Pharmaceutical Quality Management Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 25 North America: Pharmaceutical Quality Management Systems Market, by Country, 2021–2030 (USD Million)
Table 26 North America: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 27 North America: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 28 North America: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 29 U.S.: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 30 U.S.: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 31 U.S.: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 32 Canada: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 33 Canada: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 34 Canada: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 35 Europe: Pharmaceutical Quality Management Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 36 Europe: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 37 Europe: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 38 Europe: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 39 Germany: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 40 Germany: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 41 Germany: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 42 France: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 43 France: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 44 France: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 45 U.K.: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 46 U.K.: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 47 U.K.: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 48 Italy: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 49 Italy: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 50 Italy: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 51 Spain: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 52 Spain: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 53 Spain: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 54 Ireland: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 55 Ireland: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 56 Ireland: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 57 Belgium: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 58 Belgium: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 59 Belgium: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 60 Netherlands: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 61 Netherlands: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 62 Netherlands: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 63 Rest of Europe: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 64 Rest of Europe: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 65 Rest of Europe: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 66 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 67 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 68 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 69 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 70 China: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 71 China: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 72 China: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 73 Japan: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 74 Japan: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 75 Japan: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 76 India: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 77 India: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 78 India: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 79 Singapore: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 80 Singapore: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 81 Singapore: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 82 Malaysia: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 83 Malaysia: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 84 Malaysia: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 85 Philippines: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 86 Philippines: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 87 Philippines: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 88 Vietnam: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 89 Vietnam: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 90 Vietnam: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 91 Rest of Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 92 Rest of Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 93 Rest of Asia-Pacific: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 94 Latin America: Pharmaceutical Quality Management Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 95 Latin America: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 96 Latin America: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 97 Latin America: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 98 Brazil: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 99 Brazil: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 100 Brazil: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 101 Mexico: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 102 Mexico: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 103 Mexico: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 104 Rest of Latin America: Regulatory Agencies for Pharmaceutical Quality Management Systems
Table 105 Rest of Latin America: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 106 Rest of Latin America: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 107 Rest of Latin America: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 108 Middle East & Africa: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021–2030 (USD Million)
Table 109 Middle East & Africa: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021–2030 (USD Million)
Table 110 Middle East & Africa: Pharmaceutical Quality Management Systems Market, by End User, 2021–2030 (USD Million)
Table 111 Recent Developments, by Company, 2020–2023
Table 112 Pharmaceutical Quality Management Systems Market: Competitive Benchmarking by Solution
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referred for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Applications of QMS In the Pharmaceutical Industry
Figure 8 Global Pharmaceutical Quality Management Systems Market, by Solution Type, 2023 Vs. 2030 (USD Million)
Figure 9 Global Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2023 Vs. 2030 (USD Million)
Figure 10 Global Pharmaceutical Quality Management Systems Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Pharmaceutical Quality Management Systems Market, by Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 Global Pharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 14 Global Increase in The Number of Personalized Medicines, 2008–2020
Figure 15 Advantages of Integrating Ai into Pharmaceutical QMS
Figure 16 Global Pharmaceutical Quality Management Systems Market, by Solution Type, 2023 Vs. 2030 (USD Million)
Figure 17 Global Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2023 Vs. 2030 (USD Million)
Figure 18 Global Pharmaceutical Quality Management Systems Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 19 Global Pharmaceutical R&D Expenditure (2016–2024)
Figure 20 Global Pharmaceutical Quality Management Systems Market Assessment, by Country/Region, 2023 Vs. 2030 (USD Million)
Figure 21 North America: Pharmaceutical Quality Management Systems Market Snapshot
Figure 22 Europe: Pharmaceutical Quality Management Systems Market Snapshot
Figure 23 Asia-Pacific: Pharmaceutical Quality Management Systems Market Snapshot
Figure 24 India's Drug & Pharmaceutical Export Trend, 2017–2022
Figure 25 Clinical Trial Activities in Malaysia, 2015-2025
Figure 26 Latin America: Pharmaceutical Quality Management Systems Market Snapshot
Figure 27 Key Growth Strategies Adopted by Leading Players (2020-2023)
Figure 28 Pharmaceutical Quality Management Systems Market: Competitive Benchmarking, by region
Figure 29 Competitive Dashboard: Pharmaceutical Quality Management Systems Market
Figure 30 Global Pharmaceutical Quality Management Systems Market Ranking Analysis, by Key Players (2022)
Figure 31 Honeywell International Inc.: Financial Overview (2022)
Figure 32 IQVIA Holding Inc.: Financial Overview (2022)
Figure 33 Dassault Systèmes SE: Financial Overview (2022)
Figure 34 Körber AG: Financial Overview (2022)
Figure 35 ANTARES VISION S.P.A.: Financial Overview (2022)
Figure 36 Hexagon AB: Financial Overview (2022)
Figure 37 Ideagen PLC: Financial Overview (2020)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
